Alemtuzumab Pregnancy and Breast Feeding Warnings

Alemtuzumab is also known as: Campath

Overview

Women should use effective birth control methods (eg, condoms) while receiving Alemtuzumab and for 6 months after the last dose. Alemtuzumab may cause harm to the fetus. If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Alemtuzumab while you are pregnant. It is not known if Alemtuzumab is found in breast milk. Do not breast-feed while you are using Alemtuzumab and for at least 3 months after your last dose of Alemtuzumab .

Alemtuzumab Pregnancy Warnings

Alemtuzumab has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Since human IgG crosses the placenta, alemtuzumab may also cross the placenta and induce B and T lymphocyte depletion in the fetus. Alemtuzumab is only recommended for use during pregnancy when benefit outweighs risk.

Alemtuzumab Lactation Warnings

There are no data on the excretion of alemtuzumab into human milk. Since human IgG is excreted in human milk, the manufacturer recommends discontinuation of breast-feeding during alemtuzumab treatment and for at least 3 months after the last dose.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.